213 related articles for article (PubMed ID: 19073965)
1. High-throughput biochemical kinase selectivity assays: panel development and screening applications.
Card A; Caldwell C; Min H; Lokchander B; Hualin Xi ; Sciabola S; Kamath AV; Clugston SL; Tschantz WR; Leyu Wang ; Moshinsky DJ
J Biomol Screen; 2009 Jan; 14(1):31-42. PubMed ID: 19073965
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule kinase-inhibitor target assessment.
Kung C; Shokat KM
Chembiochem; 2005 Mar; 6(3):523-6. PubMed ID: 15696508
[TBL] [Abstract][Full Text] [Related]
3. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
[TBL] [Abstract][Full Text] [Related]
4. Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.
Vieth M; Erickson J; Wang J; Webster Y; Mader M; Higgs R; Watson I
J Med Chem; 2009 Oct; 52(20):6456-66. PubMed ID: 19791746
[TBL] [Abstract][Full Text] [Related]
5. Development of LanthaScreen cellular assays for key components within the PI3K/AKT/mTOR pathway.
Carlson CB; Robers MB; Vogel KW; Machleidt T
J Biomol Screen; 2009 Feb; 14(2):121-32. PubMed ID: 19196698
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening for kinase inhibitors.
von Ahsen O; Bömer U
Chembiochem; 2005 Mar; 6(3):481-90. PubMed ID: 15742384
[TBL] [Abstract][Full Text] [Related]
7. High-throughput, cell-free, liposome-based approach for assessing in vitro activity of lipid kinases.
Demian DJ; Clugston SL; Foster MM; Rameh L; Sarkes D; Townson SA; Yang L; Zhang M; Charlton ME
J Biomol Screen; 2009 Aug; 14(7):838-44. PubMed ID: 19641220
[TBL] [Abstract][Full Text] [Related]
8. Hit to lead account of the discovery of bisbenzamide and related ureidobenzamide inhibitors of Rho kinase.
Morwick T; Büttner FH; Cywin CL; Dahmann G; Hickey E; Jakes S; Kaplita P; Kashem MA; Kerr S; Kugler S; Mao W; Marshall D; Paw Z; Shih CK; Wu F; Young E
J Med Chem; 2010 Jan; 53(2):759-77. PubMed ID: 20000469
[TBL] [Abstract][Full Text] [Related]
9. Single cell network profiling (SCNP): mapping drug and target interactions.
Covey TM; Putta S; Cesano A
Assay Drug Dev Technol; 2010 Jun; 8(3):321-43. PubMed ID: 20158439
[TBL] [Abstract][Full Text] [Related]
10. Predicting kinase selectivity profiles using Free-Wilson QSAR analysis.
Sciabola S; Stanton RV; Wittkopp S; Wildman S; Moshinsky D; Potluri S; Xi H
J Chem Inf Model; 2008 Sep; 48(9):1851-67. PubMed ID: 18717582
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery process for kinase inhibitors.
Weinmann H; Metternich R
Chembiochem; 2005 Mar; 6(3):455-9. PubMed ID: 15742380
[No Abstract] [Full Text] [Related]
12. Analysis of kinase inhibitor selectivity using a thermodynamics-based partition index.
Cheng AC; Eksterowicz J; Geuns-Meyer S; Sun Y
J Med Chem; 2010 Jun; 53(11):4502-10. PubMed ID: 20459125
[TBL] [Abstract][Full Text] [Related]
13. Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology.
Perrin D; Frémaux C; Scheer A
J Biomol Screen; 2006 Jun; 11(4):359-68. PubMed ID: 16751332
[TBL] [Abstract][Full Text] [Related]
14. An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors.
Chopra P; Nanda K; Chatterjee M; Bajpai M; Dastidar SG; Ray A
Anal Biochem; 2008 Sep; 380(1):143-5. PubMed ID: 18570885
[TBL] [Abstract][Full Text] [Related]
15. Doing more than just the structure-structural genomics in kinase drug discovery.
Marsden BD; Knapp S
Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
[TBL] [Abstract][Full Text] [Related]
16. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands.
Simard JR; Rauh D
Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785
[TBL] [Abstract][Full Text] [Related]
18. Trends in kinase selectivity: insights for target class-focused library screening.
Posy SL; Hermsmeier MA; Vaccaro W; Ott KH; Todderud G; Lippy JS; Trainor GL; Loughney DA; Johnson SR
J Med Chem; 2011 Jan; 54(1):54-66. PubMed ID: 21128601
[TBL] [Abstract][Full Text] [Related]
19. A kinase-focused compound collection: compilation and screening strategy.
Sun D; Chuaqui C; Deng Z; Bowes S; Chin D; Singh J; Cullen P; Hankins G; Lee WC; Donnelly J; Friedman J; Josiah S
Chem Biol Drug Des; 2006 Jun; 67(6):385-94. PubMed ID: 16882313
[TBL] [Abstract][Full Text] [Related]
20. Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors.
Kashem MA; Nelson RM; Yingling JD; Pullen SS; Prokopowicz AS; Jones JW; Wolak JP; Rogers GR; Morelock MM; Snow RJ; Homon CA; Jakes S
J Biomol Screen; 2007 Feb; 12(1):70-83. PubMed ID: 17166826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]